Bangladesh approves Janssen vaccine
Published : Tuesday, 15 June, 2021 at 6:41 PM Count : 641
Bangladesh has approved the emergency use of Janssen COVID-19 vaccine as the sixth vaccine.
The Directorate General of Drug Administration (DGDA) approved the Emergency Use Authorization (EUA) for Janssen vaccine on Tuesday.
The Line Director (MNC&H) of the Directorate General of Health Services (DGHS) applied for the approval as the local distributor of the vaccine, said a DGDA press release.
With the approval of this vaccine, produced by Janssen Cilag International NV (Belgium), the DGDA has approved six Covid-19 vaccines for emergency use in the country.
The five other emergency authorised Covid vaccines are Covishield produced by Serum Institute of India, Sputnik V produced by Generium Joint Stock Company of Russia, Sinopharm produced by Beijing Institute of Biological Products Co. Ltd of China, Pfizer vaccine manufactured by Pfizer Manufacturing Belgium NV, and Coronavac produced by Sinovac Life Sciences Ltd of China.
Janssen COVID-19 vaccine got the World Health Organisation emergency use listing on March 12.